Printer Friendly
The Free Library
14,650,981 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Medtronic Announces European Launch of First-Ever Left-Heart Cardiac Resynchronisation Lead with Unique Fixation Lobes.


MINNEAPOLIS -- Medtronic announced today the European introduction of the Medtronic Attain StarFix(TM) OTW OTW Otherwise
OTW Off The Wall
OTW On the Way
OTW On the Whole
OTW Of The World (online TV network)
OTW On The Web
OTW Out the Window (display/graphics)
OTW On The Water
 (over-the-wire) lead (Model 4195), the first-ever cardiac resynchronisation therapy (CRT (1) (C RunTime) See runtime library.

(2) (Cathode Ray Tube) A vacuum tube used as a display screen in a computer monitor or TV. The viewing end of the tube is coated with phosphors, which emit light when struck by electrons.
) left-heart lead to offer customizable fixation technology. With the Attain StarFix lead, physicians have a new solution for achieving successful placement and stability of the left-heart lead in heart failure patients receiving an implanted CRT device. The design of left-heart leads is important, since some patients' vein structures can make it difficult to secure the lead, which delivers electrical pulses from the CRT device to the left ventricle left ventricle
n.
The chamber on the left side of the heart that receives the arterial blood from the left atrium and contracts to force it into the aorta.
 to improve heart failure symptoms and slow the progression of heart failure.

The Attain StarFix's unique design includes three soft lobes near the lead tip that, when expanded, enable stable placement of the lead tip within a target vein in the left ventricle. As necessary, the lobes can be relaxed to allow for acute repositioning of the lead. This exclusive lead technology is expected to advance the treatment of heart failure by making CRT available to patients whose heart vein sizes, configurations and locations formerly presented difficult challenges in lead placement. It is the industry's first left-heart lead that can be customized to fit a variety of vein sizes, and the flexibility in lead placement may decrease the potential for extracardiac or phrenic nerve phrenic nerve
n.
A nerve that arises mainly from the fourth cervical nerve and is primarily the motor nerve of the diaphragm but also sends sensory fibers to the pericardium.
 stimulation. The Attain StarFix lead is another example of Medtronic's leadership in introducing innovative heart failure technologies to help physicians better manage cardiac disease.

"With the Attain StarFix's new lobe technology, physicians now have a lead option that can be safely secured in even the most challenging cardiac veins," said Herbert Naegele, M.D., St. Adolf-Stift Medical Center, Reinbek, Germany, who implanted a Medtronic InSync Maximo(TM) CRT system in a heart failure patient today using the world's first commercially available Attain StarFix lead. "With enhanced lead stability, we can help more heart failure patients achieve the tremendous benefits of CRT."

The Medtronic Attain StarFix unipolar lead unipolar lead
n.
1. A lead of an electrocardiograph in which one electrode is placed on the chest in the vicinity of the heart or on one of the limbs, while the other is placed at an area of zero potential.

2.
 has a 5-French diameter - smaller than the lead in a common pencil - and is available in 79 cm., 88 cm., and 103 cm. lengths. After guide wire and/or stylet stylet /sty·let/ (sti´lit)
1. a wire run through a catheter or cannula to render it stiff or to remove debris from its lumen.

2. a slender probe.


sty·let
n.
1.
 placement and delivery of the lead using a catheter, the lead's lobes can be deployed up to 24-French diameter - about one-quarter inch - firmly fixing the electrode in place and reducing the potential for dislodgment during catheter withdrawal.

Heart failure is a chronic condition afflicting more than 22 million people worldwide. Approximately one-third of these patients have dysynchronous beating of the left and right ventricles that interferes with the heart's ability to pump adequate blood supply throughout the body. According to the European Society of Cardiology The European Society of Cardiology (ESC) represents more than 50,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the impact of cardiovascular disease in Europe. , American College of Cardiology The American College of Cardiology (ACC) is a nonprofit medical association established in 1949 to educate, research and influence health care public policy. The president for the 2006–2007 year is Steven E. Nissen. [1] The organization has 39 chapters in the U.S.  and American Heart Association American Heart Association (AHA),
n.pr a national voluntary health agency that has the goal of increasing public and medical awareness of cardiovascular diseases and stroke, and thereby reducing the number of associated deaths and disabilities.
, CRT is a standard-of-care therapy for these patients.

Medtronic CRT devices and leads are the most frequently used CRT products in the world to serve this patient group. Its InSync Sentry(TM) CRT defibrillation Defibrillation Definition

Defibrillation is a process in which an electronic device sends an electric shock to the heart to stop an extremely rapid, irregular heartbeat, and restore the normal heart rhythm.
 system is the world's first implantable medical therapy offering automatic fluid status monitoring in the thoracic cavity, the chest area encompassing the lungs and heart. The Medtronic InSync(R) and InSync(R) III devices restore left- and right-heart synchrony synchrony /syn·chro·ny/ (-krah-ne) the occurrence of two events simultaneously or with a fixed time interval between them.

atrioventricular (AV) synchrony
 for patients who are not indicated for implantable defibrillators. The Attain StarFix lead, which is not available in the United States, is designed to complement the Attain Model 4193 and Model 4194 over-the-wire leads, along with steerable catheters and guide wires, to facilitate placement and delivery of precise stimulation in widely varying coronary anatomies.

About Medtronic

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's Annual Report on Form 10-K for the year ended April 28, 2006. Actual results may differ materially from anticipated results.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 26, 2006
Words:639
Previous Article:Ceridian to Sell Major Portion of Its Retirement Plan Services Business to The Newport Group.
Next Article:ZIOPHARM to Present at Robert W. Baird 2006 Focus on Oncology Conference.
Topics:



Related Articles
Medtronic Announces FDA Approval of Expanded Labeling for Its Cardiac Resychronization Therapy (CRT) Biventricular Pacing Systems; Change Based on...
Medtronic Receives FDA Approval for New Cardiac Systems with Distance Wireless Telemetry; Concerto CRT-D and Virtuoso ICD Transmit Patient Data...
European Trial Shows Greater Efficacy of Dual Chamber Implantable Cardioverter-Defibrillators as Compared to Single Chamber ICDs in Patients at Risk...
Medtronic Announces Japanese Introduction of Cardiac Resynchronization Therapy with Defibrillator Capabilities for Heart Failure Patients.
Medtronic Statement Regarding the Clinical Benefits of ICD Therapy and the ACC/AHA/ESC 2006 Guidelines for Management of Patients with Ventricular...
Landmark European Trial Further Demonstrates That Cardiac Resynchronization Therapy (CRT) Reduces Morbidity and Mortality in Patients with Heart...
New Analysis Provides Additional Support for the Cost-Effectiveness of Cardiac Resynchronization Therapy (CRT) for Patients with Heart Failure.
Three of Medtronic's Heart Failure Clinical Studies to Be Highlighted at Heart Failure Society of America Annual Scientific Meeting.
Research and Markets: Examine Core Business Activities of Medtronic with This Medical Device Company Intelligence Report.
Medtronic Commences Clinical Trial of Innovative Delivery Technology for Heart Failure Patients with Implanted Cardiac Resynchronization Devices.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles